200 related articles for article (PubMed ID: 24690905)
21. [Expression of suppressor of cytokine signaling in peripheral blood monocular cells of patients with Vogt-Koyanagi-Harada disease].
Liu YX; Wang H; Peng XY; Zhou ZC
Zhonghua Yan Ke Za Zhi; 2009 Nov; 45(11):1015-9. PubMed ID: 20137421
[TBL] [Abstract][Full Text] [Related]
22. Dominance of activated T cells and interleukin-6 in aqueous humor in Vogt-Koyanagi-Harada disease.
Norose K; Yano A; Wang XC; Tokushima T; Umihira J; Seki A; Nohara M; Segawa K
Invest Ophthalmol Vis Sci; 1994 Jan; 35(1):33-9. PubMed ID: 8300361
[TBL] [Abstract][Full Text] [Related]
23. Promoter Hypermethylation of GATA3, IL-4, and TGF-β Confers Susceptibility to Vogt-Koyanagi-Harada Disease in Han Chinese.
Zhu Y; Yu H; Qiu Y; Ye Z; Su W; Deng J; Cao Q; Yuan G; Kijlstra A; Yang P
Invest Ophthalmol Vis Sci; 2017 Mar; 58(3):1529-1536. PubMed ID: 28278322
[TBL] [Abstract][Full Text] [Related]
24. Higher Expression of NOD1 and NOD2 is Associated with Vogt-Koyanagi-Harada (VKH) Syndrome But Not Behcet's Disease (BD).
Deng B; Ye Z; Li L; Zhang D; Zhu Y; He Y; Wang C; Wu L; Kijlstra A; Yang P
Curr Mol Med; 2016; 16(4):424-35. PubMed ID: 26980698
[TBL] [Abstract][Full Text] [Related]
25. p38{alpha} MAP kinase controls IL-17 synthesis in vogt-koyanagi-harada syndrome and experimental autoimmune uveitis.
Commodaro AG; Bombardieri CR; Peron JP; Saito KC; Guedes PM; Hamassaki DE; Belfort RN; Rizzo LV; Belfort R; de Camargo MM
Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3567-74. PubMed ID: 20164464
[TBL] [Abstract][Full Text] [Related]
26. Disabled-2 (DAB2) Overexpression Inhibits Monocyte-Derived Dendritic Cells' Function in Vogt-Koyanagi-Harada Disease.
Yi S; Chang R; Hu J; Qiu Y; Wang Q; Cao Q; Yuan G; Su G; Zhou C; Wang Y; Kijlstra A; Yang P
Invest Ophthalmol Vis Sci; 2018 Sep; 59(11):4662-4669. PubMed ID: 30267088
[TBL] [Abstract][Full Text] [Related]
27. Increased Complement 3a Receptor is Associated with Behcet's disease and Vogt-Koyanagi-Harada disease.
Wang C; Cao S; Zhang D; Li H; Kijlstra A; Yang P
Sci Rep; 2017 Nov; 7(1):15579. PubMed ID: 29138505
[TBL] [Abstract][Full Text] [Related]
28. TET2-mediated upregulation of 5-hydroxymethylcytosine in LRRC39 promoter promotes Th1 response in association with downregulated Treg response in Vogt-Koyanagi-Harada disease.
Zhang W; Chen Z; Yi K; Su G; Liu Y; Deng Y; Zhang Y; Cao Q; Pu Y; Luo X; Lai Y; Yang P
Clin Immunol; 2023 May; 250():109323. PubMed ID: 37019422
[TBL] [Abstract][Full Text] [Related]
29. Ocular infiltrating CD4+ T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens.
Sugita S; Takase H; Taguchi C; Imai Y; Kamoi K; Kawaguchi T; Sugamoto Y; Futagami Y; Itoh K; Mochizuki M
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2547-54. PubMed ID: 16723469
[TBL] [Abstract][Full Text] [Related]
30. Inhibitory effect of rapamycin and dexamethasone on production of IL-17 and IFN-gamma in Vogt-Koyanagi-Harada patients.
Yang K; Wen J; Liu X; Kijlstra A; Chen L; Chi W; Zhou H; Huang X; Yang P
Br J Ophthalmol; 2009 Feb; 93(2):249-53. PubMed ID: 19019941
[TBL] [Abstract][Full Text] [Related]
31. Decreased interleukin(IL)-35 Expression is Associated with Active Intraocular Inflammation in Vogt-Koyanagi-Harada (VKH) Disease.
Hu J; Qin Y; Yi S; Wang C; Yang J; Yang L; Wang L; Kijlstra A; Yang P; Li H
Ocul Immunol Inflamm; 2019; 27(4):595-601. PubMed ID: 29498905
[No Abstract] [Full Text] [Related]
32. Decreased microRNA-155 expression in ocular Behcet's disease but not in Vogt Koyanagi Harada syndrome.
Zhou Q; Xiao X; Wang C; Zhang X; Li F; Zhou Y; Kijlstra A; Yang P
Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5665-74. PubMed ID: 22815348
[TBL] [Abstract][Full Text] [Related]
33. Activation of the liver X receptor inhibits Th17 and Th1 responses in Behcet's disease and Vogt-Koyanagi-Harada disease.
Wu L; Wen H; Zhou Y; Yu H; Liu Y; Bai L; Kijlstra A; Yang P
Curr Mol Med; 2014; 14(6):712-22. PubMed ID: 25056541
[TBL] [Abstract][Full Text] [Related]
34. Upregulation of T-bet expression in peripheral blood mononuclear cells during Vogt-Koyanagi-Harada disease.
Li B; Yang P; Zhou H; Huang X; Jin H; Chu L; Gao Y; Zhu L; Kijlstra A
Br J Ophthalmol; 2005 Nov; 89(11):1410-2. PubMed ID: 16234441
[TBL] [Abstract][Full Text] [Related]
35. TLR3 and TLR4 But not TLR2 are Involved in Vogt-Koyanagi- Harada Disease by Triggering Proinflammatory Cytokines Production Through Promoting the Production of Mitochondrial Reactive Oxygen Species.
Liang L; Tan X; Zhou Q; Tian Y; Kijlstra A; Yang P
Curr Mol Med; 2015; 15(6):529-42. PubMed ID: 26238371
[TBL] [Abstract][Full Text] [Related]
36. Increased Expression of Indoleamine 2,3-Dioxygenase (IDO) in Vogt-Koyanagi-Harada (VKH) Disease May Lead to a Shift of T Cell Responses Toward a Treg Population.
Zhang L; Huang Y; Cui X; Tan X; Zhu Y; Zhou W; Wang C; Yuan G; Cao Q; Su G; Kijlstra A; Yang P
Inflammation; 2020 Oct; 43(5):1780-1788. PubMed ID: 32435912
[TBL] [Abstract][Full Text] [Related]
37. Absence of recognition of common melanocytic antigens by T cells isolated from the cerebrospinal fluid of a Vogt-Koyanagi-Harada patient.
Abad S; Wieërs G; Colau D; Wildmann C; Delair E; Dhote R; Brézin AP; Kawakami Y; Coulie PG; van der Bruggen P
Mol Vis; 2014; 20():956-69. PubMed ID: 24991188
[TBL] [Abstract][Full Text] [Related]
38. Th lymphocyte subsets in patients with Vogt-Koyanagi-Harada disease.
Liang L; Peng XY; Wang H
Int J Ophthalmol; 2019; 12(2):207-211. PubMed ID: 30809474
[TBL] [Abstract][Full Text] [Related]
39. Bcl-2 expression by CD4 T lymphocytes in Vogt-Koyanagi-Harada disease.
Ohta K; Yoshimura N
Ocul Immunol Inflamm; 2002 Jun; 10(2):93-103. PubMed ID: 12778345
[TBL] [Abstract][Full Text] [Related]
40. miR-23a, miR-146a and miR-301a confer predisposition to Vogt-Koyanagi-Harada syndrome but not to Behcet's disease.
Hou S; Ye Z; Liao D; Bai L; Liu Y; Zhang J; Kijlstra A; Yang P
Sci Rep; 2016 Jan; 6():20057. PubMed ID: 26818976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]